Loading market data...
ADVERTISEMENT
Banner
Latest Top News

Should You Buy the Dip? Blue Jet’s 10% Crash Has Analysts Divided

Unknown Apr 02, 2026 800 Views
Should You Buy the Dip? Blue Jet’s 10% Crash Has Analysts Divided
1. Earnings Shock Triggers Sharp Sell-Off   Shares of midcap pharma firm Blue Jet Healthcare plunged 10% on July 22, hitting a low of Rs 906.15 on the NSE. - Q1FY26 net profit dropped 17% quarter-on-quarter to Rs 91 crore - EBITDA fell 13.1% to Rs 121 crore, with margin...

Stay Ahead – Explore Now! Prism Secures ₹885 Crore Tax Relief Ahead of Planned IPO